BIO RAD LABS INC (BIO) — Hedge Fund Ownership Q1 2026
BIO
- BIO RAD LABS INC (BIO) is held by 4 of 82 tracked hedge funds, with Ariel Investments (2%) and Longleaf Partners / Southeastern Asset Management (2%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in BIO holdings came from First Eagle Investment Management (+1%) and Ariel Investments (+3%), highlighting conviction.
- The biggest decreases in BIO holdings came from Longleaf Partners / Southeastern Asset Management (-28%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to BIO RAD LABS INC (BIO) by -0.1% vs the prior quarter and +33% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Ariel Investments
|
2.45% | 786K | +2.78% | +8.46% | $219.1M | $278.75 | — |
| 2 |
Longleaf Partners / Southeastern Asset Management
|
2.23% | 163K | -28.48% | -49.72% | $45.4M | $278.75 | — |
| 3 |
First Pacific Advisors Steven Romick
|
1.62% | 407K | +1.47% | +9.34% | $113.6M | $278.75 | — |
| 4 |
First Eagle Investment Management
|
1.23% | 2.6M | +1.26% | +66.18% | $725.5M | $278.75 | — |
| 4 | Total | — | 4.0M | -0.13% | +32.53% | $1.10B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.